Napoleone Ferrara is an Italian-American molecular biologist who joined University of California, San Diego Moores Cancer Center in 2013 after a career in Northern California at the biotechnology giant Genentech, where he pioneered the development of new treatments for angiogenic diseases such as cancer, age-related macular degeneration (AMD), and diabetic retinopathy. At Genentech, he discovered VEGF—and made the first anti-VEGF antibody—which suppresses growth of a variety of tumors. These findings helped lead to development of the first clinically available angiogenesis inhibitor, bevacizumab (Avastin), which prevents the growth of new blood vessels into a solid tumor and which has become part of standard treatment for a variety of cancers. Ferrara's work led also to the development of ranibizumab (Lucentis), a drug that is highly effective at preventing vision loss in intraocular neovascular disorders.
Laura Perin, Napoleone Ferrara, and Matteo Garbelotto
The University of Catania is a university located in Catania, Sicily. Founded in 1434, it is the oldest university in Sicily, the 13th oldest in Italy, and the 29th oldest university in the world. With a population of over 60,000 students, it is the main university in Sicily.
Detail of the University of Catania, from the faculty of humanities in the Monastery of San Nicolò l'Arena
The Palazzo dell'Università, seat of the University.